Cases 11 - 20 of 34
AstraZeneca AB et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2020cv01180
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. v. Apotex, Inc. et al
as 1:2020cv00189
Defendant:
Macleods Pharmaceuticals Ltd., Cipla Limited, Apotex, Inc. and others
Plaintiff:
Gilead Sciences, Inc.
Cause Of Action: 35 U.S.C. § 1
Otsuka Pharmaceutical Co., Ltd. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv02065
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2019cv02021
Defendant:
Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Alembic Global Holding SA and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim International GmbH et al v. Macleods Pharamceuticals Ltd. et al
as 1:2019cv01864
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv01772
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv00880
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2019cv00154
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Macleods Pharmaceuticals Ltd. et al
as 1:2018cv01764
Defendant:
Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
